Workflow
北大医药股份有限公司2025年第二次临时股东大会决议公告

Group 1 - The company held its second extraordinary general meeting of shareholders on April 2, 2025, with no proposals being rejected [1][2] - A total of 327 shareholders attended the meeting, representing 211,255,706 shares, which is 35.4463% of the total voting shares [2] - The meeting was conducted in accordance with relevant laws and regulations, ensuring the legitimacy of the proceedings [2][3] Group 2 - The meeting approved several proposals, including the election of Xu Xiren, Yang Lijin, and Bao Tiemin as non-independent directors, and Li Xiaolun as a non-employee representative supervisor [5] - The legal opinion provided by the law firm confirmed that the meeting's procedures and resolutions complied with applicable laws [4] Group 3 - The company's eighth board meeting was also held on April 2, 2025, where Xu Xiren was elected as the chairman of the board [9][16] - The board also approved adjustments to the composition of its specialized committees following the resignation of the previous chairman, Qi Zixin [18] Group 4 - Xu Xiren holds a significant stake in the company, owning 132,455,475 shares, which accounts for 22.22% of the total share capital [19]